RNWAX
Price
$73.48
Change
-$1.79 (-2.38%)
Updated
Apr 3 closing price
Net Assets
62.34B
TEQPX
Price
$11.01
Change
-$0.25 (-2.22%)
Updated
Apr 3 closing price
Net Assets
7.29B
Ad is loading...

RNWAX vs TEQPX

Header iconRNWAX vs TEQPX Comparison
Open Charts RNWAX vs TEQPXBanner chart's image
American Funds New World R1
Price$73.48
Change-$1.79 (-2.38%)
VolumeN/A
Net Assets62.34B
Nuveen Emerging Markets Eq Idx Prem
Price$11.01
Change-$0.25 (-2.22%)
VolumeN/A
Net Assets7.29B
RNWAX vs TEQPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWAX vs. TEQPX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWAX is a Hold and TEQPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 62.3B vs. TEQPX (7.29B). TEQPX pays higher dividends than RNWAX: TEQPX (2.62) vs RNWAX (0.00). RNWAX was incepted earlier than TEQPX: RNWAX (23 years) vs TEQPX (15 years). RNWAX (1.66) is less costly to investors than TEQPX (0.31). RNWAX is a more actively managed with annual turnover of: 37.00 vs. TEQPX (14.00). TEQPX has a lower initial minimum investment than RNWAX: TEQPX (0) vs RNWAX (250). TEQPX annual gain was more profitable for investors over the last year : 8.43 vs. RNWAX (-2.64). TEQPX (46.24) and RNWAX (44.35) have equivalent 5 years return.
RNWAXTEQPXRNWAX / TEQPX
Total Expense Ratio1.660.31535%
Annual Report Gross Expense Ratio1.660.31535%
Fund Existence23 years15 years-
Gain YTD-0.2044.550-4%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets62.3B7.29B855%
Annual Yield % from dividends0.002.62-
Returns for 1 year-2.648.43-31%
Returns for 3 years-1.990.50-395%
Returns for 5 years44.3546.2496%
Returns for 10 years35.5327.51129%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX39.72N/A
N/A
Rydex Biotechnology C
FVDKX37.15N/A
N/A
Fidelity Value Discovery K
LSCRX20.51N/A
N/A
Loomis Sayles Small Cap Value Retail
HFDRX18.09N/A
N/A
Hartford Schroders US MidCap Opps R3
SGENX70.49-1.45
-2.02%
First Eagle Global A